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Relationship of Sulcular Sulfide Level 
to Severity of Periodontal Disease 
and BANA Test
Manabu Morita* and Hom-Lay Wang†
Background: Volatile sulfur compounds (VSC), such as hydro-
gen sulfide and methyl mercaptan, are toxic metabolites pro-
duced by periodontal pathogens. Their relationship to periodontal
disease severity is not yet fully understood. Hence, the aims of
this study were to: 1) examine the relationship between sulcu-
lar sulfide (pS) levels and severity of periodontal disease and 2)
examine the link between pS level and the BANA (benzoyl-DL-
arginine-naphthylamide) test.
Methods: Seventy systemically healthy subjects with a mean
age of 53.0 ± 13.8 years participated. Three sites were selected
from each subject based upon radiographic bone loss (RBL): RBL
<2 mm, healthy; RBL ≥2 to <4, low to moderate; RBL ≥4 mm,
severe. Periodontal parameters, probing depth (PD), clinical
attachment level (CAL), and bleeding on probing (BOP), were
recorded. The pS level was measured using a portable sulfide
monitor in a digital score ranging from 0.0 (<107 M of S) to
5.0 (≥102 M of S) in increments of 0.5. The presence of spe-
cific bacteria in subgingival plaque was detected using BANA
test.
Results: The mean pS level was 0.10 ± 0.23, 0.36 ± 0.48,
and 1.10 ± 0.87 for healthy, low to moderate, and severe dis-
ease sites, respectively, and was statistically different (P <0.001).
The pS level was positively correlated with the BANA test, and
was higher in untreated subjects than maintenance subjects (P
<0.01).
Conclusions: The pS level may be a potential indicator for
detecting severity of periodontal disease and identifying bacte-
ria that are capable of hydrolyzing BANA. J Periodontol 2001;
72:74-78.
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Toxic metabolites of bacterial originare implicated as importantdestructive factors in periodontal
disease. Volatile sulfur compounds
(VSC), such as hydrogen sulfide, methyl
mercaptan, and dimethyl sulfide are toxic
metabolites produced by microorganisms
in the periodontal environment.1-6 A few
clinical reports have shown positive cor-
relations among sulcular sulfide levels to
degree of gingival inflammation7 and
probing depth.8-10 However, the rela-
tionship between sulcular sulfide level
and the severity of periodontal disease
remains unknown.
For determination of VSC in peri-
odontal pockets, gas chromatography
has often been used.7,9,10 However, this
measurement device requires some tech-
nical expertise and is costly and time
consuming. Hence, it is not practical for
clinical usage. Recently, a portable mon-
itor that provides real-time chairside
information on sulcular sulfide levels (pS
levels) has been developed. With this
device, it has become possible to mea-
sure sulfide levels in periodontal pock-
ets.
In an in vitro study, Persson et al.11
demonstrated that Gram-negative anaer-
obic bacteria taken from periodontal
pockets were capable of producing hydro-
gen sulfide and methyl mercaptan in
human serum. This is especially true with
3 putative periodontal pathogens, Tre-
ponema denticola, Porphyromonas gin-
givalis, and Bacteroides forsythus, since
they produce copious amounts of hydro-
gen sulfide and methyl mercaptan.12
Since these bacteria can be detected
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through their ability to hydrolyze synthetic peptide ben-
zoyl-DL-arginine-naphthylamide (BANA), the BANA
test was developed and has been used as a potential
diagnostic tool for periodontal disease.13,14 However, the
relationship between the presence of these bacteria and
sulcular sulfide levels has not yet been clarified.
The purpose of this study was to examine: 1) the
correlation between periodontal disease severity and
pS levels using the portable sulfide monitor and 2) the
link between the pS level and BANA test.
MATERIALS AND METHODS
Study Population
A power calculation was performed to determine the
sample size required. The estimated standard devia-
tion of the measurement parameters (probing depth,
clinical attachment level) was chosen as 0.35 mm.
The minimum detecting difference was selected at 0.16
mm.15 A minimum number of 67 subjects was required
to allow a 95% chance of detecting a statistically sig-
nificant difference with α set at 0.05 and the power of
the study set at 80%.
After the Institutional Review Board of the Univer-
sity of Michigan approved the study protocol, 70 gen-
erally or locally advanced periodontal patients being
treated in Graduate Periodontics at the University of
Michigan School of Dentistry were selected. Subject
inclusion criteria were as follows: 1) adult males or
females older than 20 years of age and 2) having 3
representative sites with radiographic evidence of bone
loss (RBL): RBL <2.0 mm, healthy; RBL ≥2 to <4.0
mm, low to moderate; and RBL ≥4.0 mm, severe dis-
ease sites.16 Radiographs‡ (70 kVp, 7 mA) were taken
using the parallel technique and Rinn holders.§ RBL
was expressed as the distance in mm from the
cemento-enamel junction (CEJ) to the alveolar crest.
Subjects taking any antibiotics within the last 3 months,
having evidence of systemic disease (e.g., diabetes,
hepatic or renal failure) or infectious disease (e.g.,
hepatitis, human immunodeficiency virus, or tubercu-
losis), or evidence of pregnancy or lactation were
excluded from the study.
Examination
Probing depth (PD) and clinical attachment level (CAL)
were recorded utilizing the University of North Car-
olina probe (read to 1 mm). CAL was expressed as a
distance (mm) from the CEJ to the base of the peri-
odontal pocket. The measurements were made to the
nearest 1 mm. BOP was recorded as present or absent
30 seconds after probing. The intra-examiner agree-
ments of PD and CAL were 0.96 and 0.95, respec-
tively, using the Pearson correlation test, when 30 peri-
odontal pockets were randomly selected from 2
patients and examined on two separate occasions.
The sulcular sulfide (pS) level was recorded using the
portable sulfide monitor. This device consists of an
electric control unit and a disposable sensor tip that
combines a standard Michigan “O” style dental probe
with a sulfide sensor. The test area was air-dried, and
the probe tip was inserted into the periodontal crevice
in a manner identical to the routine measurement of
PD (Fig. 1). The probe tip with a sulfide sensor responds
to the various forms of sulfides expected in periodon-
tally involved pockets. The electronic control unit
reports the sulfide level at each site in a digital score
ranging from 0.0 (undetectable pS; <107 M of sulfide)
to 5.0 (≥102 M of sulfide) in increments of 0.5. This
digital score, pS, is defined by pS = (7 + Log S), where
S is the molar concentration of sulfide in an ‘‘equiva-
lent model sulcus fluid.” The intra-examiner pS agree-
ment was 0.95 using the Pearson correlation coefficient
test, when examined on two separate occasions.
The commercially available diagnostic test kit¶ based
on the hydrolysis of BANA was used to assess the
presence of T. denticola, P. gingivalis, and B.
forsythus.13 After removal of supragingival plaque,
subgingival plaque of the 3 representative sites was
collected using a sterile curet. The samples were placed
on a BANA-impregnated strip along the lower border
of a test card. An upper reagent strip containing Evan’s
black dye was then activated through dampening with
distilled water, and the 2 strips were folded over so
they contacted one another. After folding, the card was
incubated at 35°C for 5 minutes.17 Results that pro-
duced a definite blue and a pale blue were recorded
as score 2 (positive) and 1 (weak positive), respec-
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‡ GX-770, Gendex Corp., Des Plaines, IL.
§ Rinn Corp., Elgin, IL.
 Diamond Probe/Perio 2000, Diamond General Development Corp., Ann
Arbor, MI.
¶ Perioscan, Oral-B, Redwood City, CA.
Figure 1.
A sulfide sensor tip inserted into a periodontal pocket.The probe tip
was inserted into the periodontal crevice in a manner identical to the
routine measurement of PD.
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tively. No reaction was recorded
as a 0 (negative).
Statistical Analysis
The data were expressed as the
mean ± standard deviation. Sta-
tistical differences of the mean
PD, CAL, pS level, and BANA
test were analyzed among 3
sites in RBL groups by a
repeated measures analysis of
variance (ANOVA). The preva-
lence of sites with BOP positive
were compared in the three bone
loss sites by a GEE (generalized
estimating equations) approach.
The difference of the mean pS
and percent of detectable pS
(0.5 or more) among the sites
with different BANA test results
were tested by 1-way ANOVA or
chi-square test. The mean value
of the pS and the BANA results
of each RBL site were compared
between untreated and mainte-
nance patients by 1-way ANOVA. Calculations were
undertaken using a statistical software package.#
The pS-positive sites were defined as those with
detectable pS (pS ≥0.5). The BANA-positive sites were
defined as those with either BANA score 1 or 2. Using
this criterion, 2 × 2 contingency tables were constructed
to calculate sensitivity and specificity in relation to
BOP. This allowed us to detect the relationship of BOP-
positive sites to pS-positive and BANA-positive sites.
Sensitivity indicated the probability that BOP-positive
sites would yield a positive test result. Specificity indi-
cated the probability that BOP-negative sites would
yield a negative test result.18
RESULTS
Subjects consisted of 32 females and 38 males with
the mean age of 53.0 ± 13.8 years. In total, there were
49 Caucasian, 9 African-American, and 12 Asian sub-
jects. Thirty-seven subjects were undergoing mainte-
nance therapy on a recall schedule of 3 months or
longer, while the remaining 33 were untreated sub-
jects.
Table 1 shows the periodontal parameters (PD, CAL,
BOP), pS level, and BANA test in the 3 representative
sites with different severity of bone loss. The mean pS
level was 0.10 ± 0.23, 0.36 ± 0.48, and 1.10 ± 0.87
for healthy, low to moderate, and severe disease sites,
respectively. The highest pS score was 2.5 in the severe
sites, which corresponded to a sulfide concentration
of between 3 × 105 and 1 × 104 M. There were sig-
nificant differences for all parameters among the 3
RBL groups (P <0.001). Significant differences were
also observed for all parameters between each 2 sites
with different severity of bone loss (P <0.01).
Table 2 shows the relationship between the BANA
test result and mean pS and percentage of detectable
pS (≥0.5). The mean pS significantly correlated with
BANA score (Pearson correlation coefficient = 0.603,
P <0.001). About 98% of the BANA-positive sites
exhibited detectable pS, while only 18% of the BANA-
negative sites had detectable pS.
The mean pS level and BANA score of the sites with
different severity of bone loss were compared between
the 33 untreated subjects and 37 maintenance sub-
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Table 1.
Periodontal Parameters, pS Levels, and BANA Test Values in 3
Representative Radiographic Sites
Healthy Low to Moderate Severe P
N 70 70 70
Probing depth (mean ± SD) 2.06 ± 0.09 3.46 ± 0.86 5.23 ± 1.69 *
(Range) (1-4) (1-5) (1-10)
Clinical attachment level (mean ± SD) 1.73 ± 0.72 3.93 ± 0.64 6.90 ± 1.78 *
(Range) (1-3) (3-5) (4-13)
% BOP-positive sites 10.0 45.7 80.0 †
pS level (mean ± SD) 0.10 ± 0.23 0.36 ± 0.48 1.10 ± 0.87 *
(pS range) (0-1.0) (0-2.0) (0-2.5)
BANA test (mean ± SD) 0.29 ± 0.62 0.70 ± 0.73 1.13 ± 0.74 *
(Negative/Weak/Positive) (56/8/6) (32/27/11) (15/31/24)
* P <0.001 by repeated measures ANOVA.
† P <0.001 by GEE analysis.
Table 2.
Mean pS Level and Percentage of Sites
With Detectable pS (pS ≥0.5) According 
to the Results of BANA Test
BANA Test
Negative Weak Positive Positive P
N 103 66 41
Mean ± SD pS 0.14 ± 0.39 0.65 ± 0.69 1.29 ± 0.72 *
% of detectable pS 17.5 66.7 97.6 †
* P <0.001 by 1-way ANOVA.
† P <0.001 by chi-square test.
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hydrogen sulfide generated in GCF and the GCF vol-
ume. Hydrogen sulfide generated in GCF increased
with severity of gingival index.20 Coil and Tonzetich9
analyzed the VSC from gingival crevices of 17 sub-
jects. Crevicular sites that were either deep (PD ≥4
mm) or inflamed (BOP positive) exhibited significantly
higher total sulfur contents than corresponding shal-
low (PD ≤3 mm) or non-inflamed (BOP negative) sites.
The clinical relationship between periodontal dis-
ease and VSC is also supported by in vitro studies.2,6
The highest pS level score observed in the present
study (2.5, 3 × 105 to 1 × 104 M of sulfide) is equiv-
alent to 0.96 to 3.2 ppm of sulfide. Experiments have
demonstrated that exposure to 2 ppm of hydrogen sul-
fide and methyl mercaptan reduced total protein pro-
duction in human gingival fibroblasts by 18% and 35%,
respectively.2 Therefore, periodontal pockets have
enough VSC to influence the health of the periodon-
tium. Ratcliff and Johnson6 reviewed articles describ-
ing the possible roles of VSC and speculated that VSC
might be actively involved in the pathogenesis of peri-
odontal disease.
The mean pS and percentage of sites with detectable
pS correlated well with the BANA test (r = 0.603, P
<0.001). This finding indicates that pS level is a pos-
sible predictor for three periodontal pathogens (T. den-
ticola, P. gingivalis, and B. forsythus) as well as for
periodontal disease progression. However, 17.5% of
sites that were BANA test negative showed detectable
pS. There might be other microbes producing VSC in
subgingival plaque as well. Efforts to clarify the asso-
ciation between pS and an expanded panel of sub-
gingival bacteria are needed. Hence, pS level obtained
using the sulfide monitor might provide adjunctive
information for predicting the presence of periodontal
pathogens in patients.
The sensitivity and specificity of pS measurements
calculated by the 2 × 2 contingency table were 87%
and 83%, respectively, which were slightly higher than
those of the BANA test (sensitivity, 84%; specificity,
77
jects. As listed in Table 3, the sites with low to moder-
ate and severe bone loss in untreated subjects exhib-
ited significantly higher pS level and BANA test scores
than those in regular maintenance subjects (P <0.01).
The use of pS level or BANA test to differentiate
between BOP-positive sites and BOP-negative sites was
tested using the 2 × 2 contingency tables (Table 4).
The sensitivity and specificity of detectable pS related
to BOP was 87% and 83%, respectively. The BANA test
showed a sensitivity of 84% and specificity of 76%.
DISCUSSION
This study indicates that pS level increased signifi-
cantly with the severity of periodontal disease (bone
loss). The mean pS level was 0.10 ± 0.23, 0.36 ± 0.48,
and 1.10 ± 0.87 for healthy, low to moderate, and
severe bone loss sites, respectively. This is in support
of the hypothesis proposed by Fine and Mandel.19
They suggested that hydrogen sulfide generated by
causative bacteria in periodontal disease may be an
indicator for initiation or progression of periodontal
disease. Furthermore, results obtained from this trial
indicated that untreated subjects showed significantly
higher pS than maintenance subjects. This may imply
that pS level may be a useful tool for assessing out-
come of periodontal therapy.
The present study also reported that pS level sig-
nificantly correlated with PD and percent of BOP-pos-
itive sites. These results are in agreement with previ-
ous clinical reports.7-10 Solis-Gaffar et al.7 measured
levels of hydrogen sulfide production in human gingi-
val crevicular fluid (GCF). A significant positive cor-
relation (r = 0.66) was obtained between the level of
Table 3.
Mean Value and Standard Deviation of pS
Levels and BANA Test Values in Untreated
and Maintenance Subjects
Radiographic Untreated Maintenance
Bone Loss (n = 33) (n = 37) P
pS level
Healthy 0.14 ± 0.29 0.07 ± 0.17
Low to moderate 0.58 ± 0.56 0.18 ± 0.32 *
Severe 1.68 ± 0.71 0.58 ± 0.64 †
BANA test
Healthy 0.42 ± 0.75 0.16 ± 0.44
Low to moderate 0.94 ± 0.75 0.49 ± 0.65 †
Severe 1.45 ± 0.62 0.84 ± 0.73 †
* P <0.01 by ANOVA.
† P <0.001 by ANOVA.
Table 4.
Diagnostic Ratios of the pS and BANA Test
Results Compared With BOP
BOP BOP
pS Level Positive Negative BANA Test Positive Negative
Positive* 82 20 Positive† 79 28
Negative 12 96 Negative 15 88
Sensitivity: 82/94 = 87% Sensitivity: 79/94 = 84%
Specificity: 96/116 = 83% Specificity: 88/116 = 76%
* pS level ≥ 0.5.
† BANA weak positive + positive.
0027_IPC_AAP_553251  1/17/01  11:00 AM  Page 77
Sulcular Sulfide Level and Periodontal Disease Volume 72 • Number 1
76%). This can be explained in part by the fact that
VSC are produced by many periodontal pathogens,12
whereas the BANA test screens only for certain bac-
teria.13 Furthermore, VSC are potentially toxic com-
pounds to the surrounding periodontal environment.1-6
Therefore, the direct measurement of pS levels might
be more closely related to periodontal inflammation
than the BANA test.
The concern of the BANA test is its reported low
specificity.17,18 A cross-sectional study using 126 sites
from 19 periodontal subjects showed that the BANA
test had a sensitivity of 99%, whereas it yielded only
a specificity of 55%.18 However, this study incubated
the BANA test card at 55°C for 15 minutes. Studies
have looked at different incubation times and tem-
peratures based upon specificity. When a test card was
incubated at 35°C for 5 minutes, the specificity
increased to 68%17 or 74%.21 Our study yielded sim-
ilar specificity of 76% using the same conditions.
Tests to screen for existing periodontal disease may
utilize case-control and/or cross-sectional designs like
this study.22 However, in order to confirm these obser-
vations, randomized, controlled, longitudinal studies
are needed.22 It is also important to identify the sta-
tus of periodontal disease (e.g., active or non-active)
to enhance our ability to provide the most effective
treatment.23 Results obtained from this study indicate
that pS level may have potential to detect disease
activity. However, more controlled studies are still
needed to confirm this hypothesis.
In summary, sulfide levels in periodontal pockets
increased significantly in sites with increased radio-
graphic bone loss. The pS levels were positively cor-
related with the BANA test. It is then suggested that
pS level may be a potential indicator for detecting the
severity of periodontal disease.
ACKNOWLEDGMENTS
This study was supported in part by Diamond General
Development Corp., Ann Arbor, Michigan.
REFERENCES
1. Ng W, Tonzetich J. Effect of hydrogen sulfide and methyl
mercaptan on the permeability of oral mucosa. J Dent
Res 1984;63:994-997.
2. Johnson PW, Yaegaki K, Tonzetich J. Effect of volatile
thiol compounds on protein metabolism by human gin-
gival fibroblasts. J Periodont Res 1992;27:553-561.
3. Johnson PW, Ng W, Tonzetich J. Modulation of human
gingival fibroblast cell metabolism by methyl mercaptan.
J Periodont Res 1992;27:476-483.
4. Johnson P, Yaegaki K, Tonzetich J. Effect of methyl mer-
captan on synthesis and degradation of collagen. J Peri-
odont Res 1996;31:323-329.
5. Lancero H, Niu J, Johnson PW. Exposure of periodon-
tal ligament cells to methyl mercaptan reduces intra-
cellular pH and inhibits cell migration. J Dent Res
1996;75:1994-2002.
6. Ratcliff PA, Johnson PW. The relationship between oral
malodor, gingivitis, and periodontitis. A review. J Peri-
odontol 1999;70:485-489.
7. Solis-Gaffar MC, Rustogi KN, Gaffar A. Hydrogen sulfide
production from gingival crevicular fluid. J Periodontol
1980;51:603-606.
8. Rizzo AA. The possible role of hydrogen sulfide in human
periodontal disease. I. Hydrogen sulfide production in
periodontal pockets. Periodontics 1967;5:233-236.
9. Coil JM, Tonzetich J. Characterization of volatile sulphur
compound production at individual gingival crevicular
sites in humans. J Clin Dent 1992;3:97-103.
10. Persson S. Hydrogen sulfide and methyl mercaptan in
periodontal pockets. Oral Microbiol Immunol 1992;7:
378-379.
11. Persson S, Claesson R, Carlsson J. The capacity of sub-
gingival microbiotas to produce volatile sulfur com-
pounds in human serum. Oral Microbiol Immunol 1989;
4:169-172.
12. Persson S, Edlund MB, Claesson R, Carlsson J. The for-
mation of hydrogen sulfide and methyl mercaptan by
oral bacteria. Oral Microbiol Immunol 1990;5:195-201.
13. Loesche WJ, Bretz WA, Kerschensteiner D, et al. Devel-
opment of a diagnostic test for anaerobic periodontal
infections based on plaque hydrolysis of benzoyl-DL-
arginine-naphthylamide. J Clin Microbiol 1990;28:1551-
1559.
14. Beck JD, Koch GG, Rozier RG, Tudor GE. Prevalence
and risk indicators for periodontal attachment loss in a
population of older community-dwelling blacks and
whites. J Periodontol 1990;61:521-528.
15. Machtei EE, Hausmann E, Grossi SG, Dunford R, Genco
RJ. The relationship between radiographic and clinical
changes in the periodontium. J Periodont Res 1997;32:
661-666.
16. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of
risk for periodontal disease. II. Risk indicators for alve-
olar bone loss. J Periodontol 1995;66:23-29.
17. Loesche WJ, Kazor CE, Taylor GW. The optimization of
the BANA test as a screening instrument for gingivitis
among subjects seeking dental treatment. J Clin Peri-
odontol 1997;24:718-726.
18. Hemmings KW, Griffiths GS, Bulman JS. Detection of
neutral protease (Periocheck) and BANA hydrolase
(Perioscan) compared with traditional clinical methods of
diagnosis and monitoring of chronic inflammatory peri-
odontal disease. J Clin Periodontol 1997;24:110-114.
19. Fine DH, Mandel ID. Indicators of periodontal disease activ-
ity: An evaluation. J Clin Periodontol 1986;13:533-546.
20. Löe H, Silness J. Periodontal disease in pregnancy. I.
Prevalence and severity. Acta Odontol Scand 1963;21:
533-551.
21. Feitosa ACR, Amalfitano J, Loesche WJ. The effect of
incubation temperature on the specificity of the BANA
(N-benzoyl-DL-arginine-naphthylamide) test. Oral Micro-
biol Immunol 1993;8:57-61.
22. Council on Scientific Affairs, American Dental Associa-
tion. Products and methods for the diagnosis and/or
management of periodontitis. J Periodontol 1998;69:
1071-1075.
23. Armitage GC. Periodontal diseases: Diagnosis. Ann Peri-
odontol 1996;1:37-215.
Send reprint requests to: Dr. Hom-Lay Wang, Department
of Periodontics/Prevention/Geriatrics, University of Michi-
gan School of Dentistry, 1011 N. University Avenue, Ann
Arbor, MI 48109-1078. Fax: 734/936-0374; e-mail: hom-
lay@umich.edu
Accepted for publication July 7, 2000.
78
0027_IPC_AAP_553251  1/17/01  11:00 AM  Page 78
